18F-FDOPA and MRI Findings in a Case of Multiple Sclerosis.
暂无分享,去创建一个
S. Kremer | I. Namer | S. Chibbaro | C. Bund | F. Lersy
[1] E. Thouvenot,et al. 18F-FDOPA-PET in pseudotumoral brain lesions , 2020, Journal of Neurology.
[2] T. Hardy. Pseudotumoral demyelinating lesions: diagnostic approach and long-term outcome , 2019, Current opinion in neurology.
[3] David H. Miller,et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.
[4] D. Rubello,et al. 18F-DOPA PET/CT Physiological Distribution and Pitfalls: Experience in 215 Patients , 2016, Clinical nuclear medicine.
[5] F. Calabria,et al. Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT , 2012, Nuclear medicine communications.
[6] L. Kappos,et al. MR Imaging in Multiple Sclerosis: Review and Recommendations for Current Practice , 2010, American Journal of Neuroradiology.
[7] M. Kudo,et al. Monofocal acute inflammatory demyelination manifesting as open ring sign. Case report. , 2006, Neurologia medico-chirurgica.